Mechanical and radiological assessment of the influence of rhTGFβ-3 on bone regeneration in a segmental defect in the ovine tibia: Pilot study

Journal of Orthopaedic Research

Volumn 24, Issue 8, 2006, Pages 1670-1678

  Maissen, Otto ^a   Eckhardt, Christina ^a   Gogolewski, Sylwester ^a   Glatt, Markus ^b   Arvinte, Tudor ^b   Steiner, Adrian ^c   Rahn, Berton ^a   Schlegel, Urs ^a  

^a AO RESEARCH INSTITUTE   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bone defect; Bone mineral density; Stiffness monitoring; TGF 3

Indexed keywords

DRUG CARRIER; POLYLACTIDE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; BONE DEFECT; BONE DENSITY; BONE GRAFT; BONE RADIOGRAPHY; BONE REGENERATION; BONE TRANSPLANTATION; CANCELLOUS BONE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FRACTURE HEALING; IN VIVO STUDY; LOADING TEST; MEASUREMENT; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOLOGICAL PARAMETERS; RIGIDITY; SHEEP; STATISTICAL SIGNIFICANCE; TIBIA;

ABSORBABLE IMPLANTS; ANIMALS; BONE DENSITY; BONE REGENERATION; DRUG IMPLANTS; IMAGING, THREE-DIMENSIONAL; PILOT PROJECTS; POLYESTERS; RECOMBINANT PROTEINS; SHEEP; TIBIA; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3; WEIGHT-BEARING;

EID: 33747024962     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20231     Document Type: Article

References (39)

1. Kurz LT, Garfin SR, Booth RE Jr. 1989. Harvesting autogenous iliac bone grafts. A review of complications and techniques. Spine 14:1324-1331.
2. Summers BN, Eisenstein SM. 1989. Donor site pain from the ilium. A complication of lumbar spine fusion. J Bone Joint Surg Br 71:677-680.
3. Burchard H. 1989. Biology of cortical bone graft incorporation. In: Aebi M, Regazzoni P, editors. Bone transplantation. Berlin: Springer.
4. Claes LE, Heigele CA. 1999. Magnitudes of local stress and strain along bony surfaces predict the course and type of fracture healing. J Biomech 32:255-266.
5. Perren SM, Cordey J. 1980. The concept of interfragmentary strain. In: Uhthoff HK, editor. Current concepts of internal fixation of fractures. Berlin: Springer.
6. Cestro HJ, Salyer KE. 1975. Bone ingrowth into porous carbon, polyethylene, and polypropylene prostheses. J Biomed Mater Res Symp 6:1-7.
7. Sauer BW, Weinstein AM, Klawitter JJ, et al. 1974. The role of porous polymeric materials in prosthesis attachment. J Biomed Mater Res 8:145-153.
8. Assoian RK, Komoriya A, Meyers CA, et al. 1983. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 258:7155-7160.
9. Bolander ME. 1992. Regulation of fracture repair by growth factors. P S E B M 200:165-170.
10. Joyce ME, Nemeth GG, Jingushi S, et al. 1989. Expression and localization of transforming growth factor-β1 in a model of fracture healing. J Bone Joint Surg 13:460.
11. Yupeng S, Lupu L, Yunyu P, et al. 1995. Induction of osteogenesis by bovine platelet transforming growth factor-beta (TGF-β) in adult mouse femur. Chin Med J 108:914-918.
12. Centrella M, McCarthy TL, Canalis E. 1989. Effects of transforming growth factors on bone cells. Connect Tissue Res 20:267-275.
13. Joyce ME, Roberts AB, Sporn MB, et al. 1990. Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 110:2195-2207.
14. Roberts AB, Sporn MB. 1990. The transforming growth factor-βs. In: Sporn MB, Roberts AB, editors. Peptide growth factors and their receptors. Berlin: Springer.
15. Bak B, Jorgensen PH, Andreassen TT. 1991. The stimulating effect of growth hormone on fracture healing is dependent on onset and duration of administration. Clin Orthop 264:295-301.
16. Boden SD, Kang J, Sandhu H, et al. 2002. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial. 2002 Volvo Award in clinical studies. Spine 27:2662-2673.
17. den Boer FC, Wippermann BW, Blokhuis TJ, et al. 2003. Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein-1 or autologous bone marrow. J Orthop Res 21:521-528.
18. Friedlaender GE, Perry CR, Cole JD, et al. 2001. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg 1:151-158.
19. Kirker-Head CA, Gerhart TN, Armstrong R, et al. 1998. Healing bone using recombinant human bone morphogenetic protein 2 and copolymer. Clin Orthop 354:205-217.
20. Kokubo S, Fujimoto R, Yokota S, et al. 2003. Bone regeneration by recombinant human bone morphogenetic protein-2 and a novel biodegradable carrier in a rabbit ulnar defect model. Biomaterials 24:1643-1651.
21. Valentin-Opran A, Wozney J, Csimma C, et al. 2002. Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop 395:110-120.
22. Beck LS, Wong RL, DeGuzman L, et al. 1998. Combination of bone marrow and TGF-beta1 augment the healing of critical-sized bone defects. J Pharm Sci 87:1379-1386.
23. Moxham JP, Kibblewhite DJ, Dvorak M, et al. 1996. TGF-beta 1 forms functionally normal bone in a segmental sheep tibial diaphyseal defect. J Otolaryngol 25:388-392.
24. Sumner DR, Turner TM, Cohen M, et al. 2003. Aging does not lessen the effectiveness of TGFbeta2-enhanced bone regeneration. J Bone Miner Res 18:730-736.
25. Rosier RN, O'Keefe RJ, Hicks DG. 1998. The potential role of transforming growth factor beta in fracture healing. Clin Orthop 355:294-300.
26. Steffen T, Stoll T, Arvinte T, et al. 2001. Porous tricalcium phosphate and transforming growth factor used for anterior spine surgery. Eur Spine J 10(suppl. 2):132-140.
27. Pre M, Priestle JP, Cox DA, et al. 1996. The crystal structure of TGF-{beta}3 and comparison to TGF-{beta}2: implications for receptor binding. Protein Sci 5:1261-1271.
28. Lill CA, Hesseln J, Schlegel U, et al. 2003. Biomechanical evaluation of healing in a noncritical defect in a large animal model of osteoporosis. J Orthop Res 21:836-842.
29. Urist MR. 1989. Introduction to update on osteochondral allograft surgery. In: Aebi M, Regazzoni P, editors. Bone transplantation. Berlin: Springer.
30. Lind M, Overgaard S, Nguyen T, et al. 1996. Transforming growth factor-beta stimulates bone ongrowth. Hydroxyapatite-coated implants studied in dogs. Acta Orthop Scand 67:611-616.
31. Centrella M, McCarthy TL, Canalis E. 1987. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem 262:2869-2874.
32. Sporn MB, Roberts AB. 1988. Peptide growth factors are multifunctional. Nature 332:217-219.
33. Whitman M. 1997. Feedback from inhibitory SMADs. Nature 389:549-551.
34. Roberts AB, Anzano MA, Wakefield LM, et al. 1985. Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci USA 82:119-123.
35. Cheifetz S, Hernandez H, Laiho M, et al. 1990. Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. J Biol Chem 265:20533-20538.
36. Kingsley DM. 1994. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146.
37. Gombotz WR, Pankey SC, Bouchard LS, et al. 1993. Controlled release of TGF-beta 1 from a biodegradable matrix for bone regeneration. J Biomater Sci Polym Ed 5: 49-63.
38. Schmitt JM, Buck D, Bennett S, et al. 1998. Assessment of an experimental bone wax polymer plus TGF-beta 1 implanted into calvarial defects. J Biomed Mater Res 41: 584-592.
39. Gogolewski S, Jovanovic M, Perren SM, et al. 1993. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res 27:1135-1148.